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Doasearchon "drugs" and "history" andyou
would be rewarded by many titles. But many
tread an all too familiar path. The assassins and
cannabis, Homer and nepenthe, the opiates in
Shakespeare, lead through to the nineteenth
century, literary andpopularuse,opiumsmoking
andbeyond. Published newprimary research has
been short in supply and texts often recycle
familiar workandquotations. Butthere are signs
of change. A crop of recent books on
international drug policy showed the benefits of
an expansion of research in that area.' David
Courtwright's Forces ofhabit has provided an
excellent analytical oversight of the rise and
fall of drugs in history.2 But the more recent
historyofnational UKorUSdruguseandcontrol
have been relatively neglected, or considered
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as part of other topics, for example the advent
of HIV/AIDS in the 1980s.3 Research based
accounts like the short paper by Carol Smart on
British drug policy from the 1930s to the 1960s,
published nearly twenty years ago, remain rare.4
The changes in drug policies in the period
sincethe SecondWorldWarandinparticularthe
1960sand 1970sweresignificantandcontinueto
excite debate in today's fluid situation. This
review assesses three recent publications which
throwlightonthatperiod, in verydifferent ways.
Musto and Korsmeyer cover the changes in US
drugpolicy since theJohnson erainthe 1960s up
to the end ofthe Carter presidency in the 1970s.
The collection of interviews edited by Griffith
Edwards singles out some of the scientists,
researchers and clinicians who collectively have
3Virginia Berridge, AIDS in the UK: the making
ofpolicy, 1981-1994, Oxford University Press, 1996.
4Carol Smart, 'Social policy and drug addiction:
a critical study ofpolicy development', Br. J.
Addiction, 1984, 79 (1): 31-9.
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formed the "alcohol, drug and smoking field"
over the past fifty years. The part history
text/partautobiography byBingSpearcoversthe
changes in British drug policy that paralleled
those intheUS, although his frame starts earlier,
in 1916, and finishes in the 1980s. These are the
research-based texts which are lacking in the
field.
Musto and Korsmeyer's book builds on the
more general overview ofUS drug policy with
which David Musto's name has been associated
since the 1970s. The new book looks at the
sixties andseventies ingreaterdepth. Korsmeyer
has mined primary sources in presidential
archives, theLibrary ofCongress andelsewhere,
while Musto'sconnections inthedrugfieldhave
ensured access to the papers of key players like
Nixon's former drug czar, the psychiatrist Jerry
Jaffe, and Carter's adviser on drugs, Peter
Bourne. The period they cover was an exciting
oneforUSdrugpolicy. Theeraofprohibition set
inmotionbytheHarrisonNarcoticsActof1914,
and which lasted into the early 1960s, fell apart
under the pressures ofcrime and civil
disobedience; thewarinVietnam;andincreasing
consumption of illicit substances. The old
warhorses ofprohibition, in particular Harry
Anslinger, the commissioner ofthe Federal
BureauofNarcoticssincethe 1930s,disappeared
from the scene. The Johnson administration
began a three part approach to the drug problem
which was later carried through in the
administration of Richard Nixon, Johnson's
Republican successor. Nixon's attack on drugs
involvedastressonthecloseconnectionbetween
drugs and crime (a connection which remains
controversial). Foreign policy was a key
component-relations with Mexico and with
Turkey were affected by policies of border
containment (Operation Intercept) and of crop
substitution. Close connections between local
law enforcement and the federal fight were
established through the Office of Drug Abuse
Law Enforcement. AWhite HousebasedSpecial
Action Office on Drug Abuse Prevention
(SAODAP) under Jaffe's medical leadership,
5David Musto, The American disease: origins of
narcotic control, expanded ed., New York, Oxford
University Press, 1987.
saw addicts able to obtain maintenance
prescribing from government sponsored clinics
for the first time since the 1920s. The drug on
offer was oral methadone, a synthetic narcotic
developedinGermany inthe 1930s. Noneofthis
effort was an unmitigated success and in
particularfellfouloftensionswithingovernment
between different agencies. But some of the
Nixoneraorganizations surviveevenintheearly
2000s, albeit in different form.
Gerald Ford's period as president (1974-77),
bedevilled by cost-cutting, introduced a more
moderatetone.Theword "minimize" ratherthan
eradicate appeared in official policy documents,
in particular in the White Paper on Drug
Abuse, well received by a population cynical
about the imminence of victory in the war on
drugs. This attitude developedfurtherinCarter's
presidency, which, the authors note, marked the
high point of the American public's relative
acceptance of some degree ofrecreational drug
use.ThemistakemadebyCarter, andbyDrPeter
Bourne, his influential drugs adviser, was in
assuming that public mood was a fixed point.
Drug use, and its public acceptability, were both
fluid. Bourne's careless prescription for one of
his staffers, and allegations that he had used
cocaine at a party for NORML (National
OrganisationforReform oftheMarijuanaLaws)
led to his downfall. The Parents' Movement was
intheascendantwhiletheherointrade,fromIran,
Pakistan and Afghanistan, began to expand. The
heady days of the 1970s consensus were over.
This book covers important events, although
its tone is hardly exciting. The illustrations of
'men in suits" discussing drugs in committee
meetings thatpepperthepages seem alsotohave
affected the writing style. (Although a photo of
Keith Stroup of NORML bears an uncanny
resemblance to Austin Powers.) There are
thickets of detail on US policy manoeuvring
which, for a non-American readership, are
difficult to master. A summing up orconcluding
chapter or overall bibliography and listing of
the primary sources used would have been
helpful. The book has a rather unfinished air. A
novel addition is a CD of the documents used
to write the text, inserted in the back cover.
This is valuable, but also adds to the sense of
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"develop your own analysis". The tone is
circumspect and analytical themes are few.
Those that are extractable from the text are
sensible and founded on long experience of
the US drug policy scene. Musto comments that
lack of long term perspectives in politics has
consistently hindered balanced perspectives on
what policy can produce. He considers that drug
use ebbs andflows in cycles on whichpolicy has
little impact. For this assessment at least, an
historical perspective is essential.
Edwards' edited collection has one unifying
idea-thepost-Second WorldWarevolution ofa
separate "field" of addiction specialists. It also
provides, through its interview format, some
of the raw material for other studies in drug,
alcohol and smoking history. It is the second
booktobepublishedfromthe series ofAddiction
interviews which thejournal has featured for
many years. The current collection has scientists
from the USA and Canada. There arepoliticians
and practitioner policy-makers from Australia;
pioneers from the smoking field like Richard
Doll and Charles Fletcher and the less well
known Ove Ferno, the originator of nicotine
replacement therapy. There are British drugs
researchers; policy makers in the US; scientists
in post-war Europe; community activists in the
US, and researchers and policy-makers from
Scandinavia. Each section finishes with a brief
page ortwo overview from anexpert inthe field.
With such a cornucopia it is impossible to do
justice to every interview. Some overlap with
Musto's study, for example an interview with
Jaffe,andalsoonewithVincentDole,thepioneer
ofmethadone maintenance therapy in New York
in the 1960s, although Musto's book appears
not to have used this resource.
Can any general conclusions be drawn about
the growth ofthe "field"? Interviewees from the
1950s talk of how small even the alcohol field
was at that stage and how much it had grown by
the time they left it. Everyone knew everyone,
but later it was impossible to do that. The influx
ofrefugees fromEurope toAmerica was astrong
influence. Few, however, had the experiences
of Charles Lieber, an expert on the biological
aspects ofalcoholabuse, whodescribes war-time
displacement in Europe, beset by all the warring
armies;thismakeshislatereminenceallthemore
laudable. IntheUS,theFederalnarcotics "farm"
at Lexington, Kentucky, which provided both
incarceration and treatment, was a formative
influence for many researchers. International
networks were important. Scientific meetings
brought researchers together, as did the newly
established WHO, and collaborative publication
likethefamousalcoholPurpleBookofthe 1970s
forged a strong esprit de corps.6 Researchers
from the Canadian Addiction Research
Foundation, the powerhouse of research,
treatmentandpreventioninthatcountrysincethe
1940s, speak of the changes in research policy
which have seen funded research give way to
time limited grants, from "blue skies research"
to direct policy and practice relevance. The
Australians tell ofpolicy battles, ofmore recent
attempts to liberalize drug policy orofthe failed
attempt to institute a trial of heroin prescribing.
The Scandinavians offer a window into a very
different situation for research, with funding
coming from the state alcohol monopoly-even
for sociology. They outline the strong interest in
Scandinavian co-operation, in research on
policy, and a cadre ofdrug researchers who also
maintain reputations intheirgeneral disciplinary
fields.
There are vignettes which stand out. Here is
RegSmartoftheAddictionResearchFoundation
speaking of E M Jellinek, the author of the
seminal The disease concept ofalcoholism:
"Jellinek, asIrememberhim, was ashort, sortof
stooped-over, overweight man, with little hair
left. Not at all a romantic figure, but he had
married several times and he spoke often about
his relationship with a Spanish ballet dancer, as
well as his other romantic affairs. I remember
him as a great rapporteur and teller ofjokes.
"He was older when I met him and he had a
hearingaid. Ifameetingbecameboringhewould
turn the hearing aid off and go to sleep. Several
6KBruun, M Lumio, KMakela, L Pan, R Popham,
R Room, S Schmidt, 0 Skog, P Sulkunnen, and
E Osterberg, Alcohol controlpolicies in public
health perspective, Helsinki, Finnish Foundation for
Alcohol Studies, WHO Regional office for Europe,
Addiction Research Foundation of Ontario, 1975.
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times I saw people awaken him and ask him to
summarize the discussion. Usually these
summaries were very good" (p. 109).
The three interviews with characters of
importanceinthehistoryofpost-warBritishdrug
policy were of interest from my perspective.
ThesearewithJoyMott,adrugsresearcheratthe
Home Office, Thomas Bewley, formerly
consultant to the Ministry of Health on drugs
and akey force in British drug policy changes in
the 1960s; and Raj Rathod, a psychiatrist
working in Crawley New Town, who published
some ofthe earliest epidemiological research on
the spread of the new heroin epidemic outside
London inthe 1960s. Bewley's interview carries
a humorous flavour ofthe man.
"Tooting Bec was the most central mental
hospital which accepted patients from anywhere
inLondon.Inthe 1960sIusedtoadmitalcoholics
of no fixed abode and we had an alcoholism
programme. One of my registrars described it
aspatients coming infortheir 1000galloncheck
up ... A small number ofheroin addicts were
alsoadmittedasnooneelsewantedtohavemuch
todowiththematthattime.WhenIfirstwroteto
the Lancet I think I had seen about 20. I don't
think anyone else in the country had seen more
than two then. This was how I became an
'expert'" (p. 247).
Bewley went on to become influential indrug
policy and a President of the Royal College of
Psychiatrists; Rathod, by contrast, was apioneer
who remained a relative outsider.
This is a rich collection. Some interviews
are clearly better than others and some
interviewers more talented at extracting the
telling phrase or anecdote. One encounter with
theAustralianpremier, BobHawke, isalessonin
how not to do it, with closed statements rather
than open ended questions, eliciting predictably
terse responses from the politician. The text
tells us little about how the interviews were
conducted or when, and about how they have
beenedited. They were intended forpublication,
withtheconstraintsonspeakingfreelywhichthat
implies. The interviewers are key players or
researchersinthefield, severalofwhomhavenot
uncomplicated relationships with their
interviewees. Such constraints on source
production should be borne in mind. My own
interviews with one or two of these "players",
not for publication, have produced different
perspectives. As one ofthe commentaries sighs,
weallknowthattheycouldhavetoldus somuch
more.Nevertheless, thiscollectionisofvalueand
the editor to be credited for his foresight in
gathering the interviews together.
The first volume ofAddiction interviews
contained one with the former Home Office
ChiefDrugs Inspector, BingSpear. Speardiedin
1995 but his history ofBritish drug policy from
1916 to 1984 has been edited and brought to
fruition by Joy Mott, the former Home Office
researcher who is herself the subject of an
Addiction interview. Here people who are the
raw material ofhistory are both writing and
editing it, although in a different way to the
interview format in the Edwards book. Spear
has long been a legendary figure to liberalizers
in the drug policy field. Tales ofhow he knew
every addict personally on the London drug
"scene" of the 1960s, and would take his night
time walks down to Piccadilly Circus to visit
the all night chemists supplying addicts have
been told and retold. His lustre among
liberalizersderives fromhiscriticismsoftheturn
which drug policy took after the changes of
the 1960s. Spear considered that the changes in
prescribing policy and the management ofdrug
addiction that marked the implementation ofthe
1965 report of the second Brain committee
amplified rather than reduced the problem.
Specifically he argued thatpolicy was driven by
the interests of a small group of psychiatrists
who, until then, had had little interest in drugs,
but who established a treatment orthodoxy that
had disastrous results. Prescribing was taken
away from experienced general practitioners
and located in hospital-based drug dependence
units. Here psychiatrists imposed policies of
no prescribing, or ofprescribing only oral
methadone (the synthetic narcotic also being
usedintheUS atthistime).Theresult,heargued,
was the growth of a black market. Addict
numbers expanded as addicts turned away from
the clinics in search of a less restrictive
prescribing regime. His hostility was directed
in particular at Dr Philip Connell, consultant at
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the Maudsley and adviser on drugs to the
Department of Health. Spear's views have
recently been taken up and advanced with
some successbythosewhowantreinstatementof
heroin prescribing regimes.
Spearhadalreadyproducedadetailedpaperon
theevolutionofthedrug "problem" inthe 1950s
and 1960s which has been widely used by
analysts ofthatperiod.7 In the bookhetakes that
style of writing further, using mainly Home
Office papers, and articles in the medical press
from the time, as well as the review and
reminiscencewhichhasbeenpublishedbyothers
inthefieldoverthelastthirtyyears. Speartellsus
how British drug policy evolved towards the
"disaster" ofthe post Brain 2 period after 1965.
Advice from the drugs inspectorate to the first
Brain committee in the early 1960s was ignored
and the committee produced a sanguine view of
the rapidly deteriorating situation. The
inspectorate's further warnings triggered the
appointment ofthe second Brain committee, but
the implementation of its conclusions was
disastrous. The Ministry of Health delayed in
setting up the promised treatment centres,
obtaining its advice from "persons experienced
in the treatment of addiction", the psychiatrists
whom Spear obviously regarded with contempt.
The Ministry, he argues, lost control of the
situation to a clinical clique who excluded
general practitioners and others experienced in
the treatment of addiction. Changes in
prescribing practice were carried through
without liaising with the street agencies who
knewthegrassrootssituation. AtBewley'sclinic
the change to time limited oral methadone
prescribing was announced simply through a
notice posted on the door. The subsequent
medical attack on private prescribing in the
1980s arose out of the desire to impose clinical
orthodoxy, which the private sector did not
accept.
This is a well known critique in the drugs
field, which is here presented with some vigour
andindetail. Itiswritten asanhistoricalanalysis,
7H B Spear, 'The growth ofheroin addiction in
the United Kingdom', Br. J. Addiction, 1969, 64:
245-55.
but is a hybrid, a semi autobiographical
account written by an important player in drug
policy in the sixties with the intention ofarguing
the Home Office view and that of the
inspectorate. It is valuable, but also frustrating.
Timeandagain,IlongedforSpeartobreakoutof
his report writing style and tell us what went on,
with some direct "feeling." He gives some
tantalizing leads, but goes no further. Why were
thejunior inspectors "betrayed" by Home
Office administrative officials and the Chief
Inspector at the time ofthe first Brain Report
(p. 104)? Having helped initiate the second
committee, what was his view of
the report? He had argued for compulsory
notification, notinitselfaliberalpolicy-didthe
inspectorate's pressure forthe secondcommittee
rebound on them? What was going on in the
inspectorate during the period ofdelay between
1965 to 1968? The sections in which Spear
gives a personal view are valuable. But an
opportunity to explore his personal involvement
in depth and the history and role of the
inspectorate has been lost. The text has been
heavily reducedforpublication (itwasoriginally
much longer) but we have no editorial note on
howthishasbeenaccomplished. MaybeMsMott
might consider David Musto's CD idea for the
unpublished material; this is itself an historical
source.
Alongside clinicians, women academics such
asmyselfandCarolSmartwereclearlyparticular
irritants for Spear. The first chapter of his
book, which deals with the period during and
after the First World War, is framed as an attack
on my own analysis of drug policy. This is the
period of flux between 1916 and 1926, when
clinicians and the Home Office negotiated the
balance that was to operate in drug policy in the
light of the requirements of intemational drug
control. Was policy to be primarily penal in
orientation, as intheUS, orwere medical men to
be allowed to prescribe? These tensions
established the medico-legal alliance which was
to characterize drug policy for so long. I
found this chapter, the vehemence and bias ofits
attackonmyself,puzzling,inparticularsinceour
relations when Spear was alive had been
cordial; he had never voiced these criticisms to
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my face. I related it to the general agenda ofthe
book, which is to defend Spear's view of the
Home Office and to criticize "psychiatric
imperialism" in drug policy. Spear considered
that my interpretation of the 1920s cast
aspersions on the role ofthe Home Office and of
Malcolm Delevingne, the civil servant who later
became one ofthe "grand old men" of
international drugcontrol. Hesawmyanalysis as
making the medical profession the "heroes" and
Delevingne the "villain". This is not the case,
and I do not write history in the "heroes and
villains" mode. The point I make is that the
objectives of the Home Office changed over
time. Delevingne came to realize that the role of
the medical profession in the treatment of
addiction had to be recognized. What resulted
was a medico-penal alliance within which the
balance ofpowercould change to one side orthe
other. Thisbalanceoperatesin2003 asmuchasin
1926. Like Spear, I concluded that Delevingne
rather than Rolleston was the major architect of
British drug policy. It is a pity that Spear's
editor did not check my writing on this topic
where this analysis is made plain.8
In order to develop his attack, Spear disputes
my interpretation of the evidence. Pages are
occupied with detailed textual criticism. In a
review ofthis nature it would be tedious for the
readership to redispute everything in return,
although I would be happy to do this given the
space. Let me focus on a particular example.
I argue that the medical and pharmaceutical
professions as well as the vets were outraged by
the Home Office's issue of regulations under
the Dangerous Drugs Act in the 1920s. Spear
writes that I over-emphasize this. The medical
profession, he argues, should not have been
bothered by a few requirements for clinical
recordkeepingorbythecirculationofablacklist
of doctors prescribing to addicts. But this is
ahistorical; the evidence which he produces
shows that they were. The aim of historical
writing is to attain critical distance, not to
8Virginia Berridge, ' "Stamping out addiction":
the work of the Rolleston Committee, 1924-1926',
in G E Berrios and H Freeman (eds), 150 years of
Britishpsychiatry, 1841-1991, Vol. 11: The aftermath,
London, Athlone Press, 1996.
comment from an interested perspective, as
Spear does here. He writes as the Home Office
inspector. By the 1960s and 1970s, his own
period of key influence, the professions were
relatively used to the requirements ofcontrol. In
the 1920s,thesewerenew systemswhichseemed
to undermine professional freedom as well as
being excessively bureaucratic. Spear's
comments on the role of the Ministry of Health
(p. 9) show that he is unaware ofits history, that
the Ministry was only recently established in the
early 1920s. It did indeed have to win a position
of influence in drug policy in contrast to the
longer Home Office track record.
There is a further aspect to Spear's attack. At
several points, he uses words selectively which
appear to represent my views. He refers (p. 32)
to a Home Office "defeat" as if this is my
analysis and in order to criticize this
interpretation of policy. The actual words I
use present a different analysis. "In reality the
outcome was more complex than a
straightforward defeat for the Home Office. It
was recognition that narcotic policy could not
simply remain a matter of increasing state and
police regulation, as had been the case since
1916. It was henceforward to be based on some
form of partnership between the professional
ideologyofdoctorsandtheaimsofpolicyasseen
from the Home Office."9 Spear's stance raises
issuesofsource/historianrelationshipswhichare
also of interest methodologically to those of us
who work in the contemporary history field. The
general topic is worth a fuller piece.
Thesebooksgiveasenseoftherichness which
awaits in the study of science and policy in
the drugs, smoking and alcohol field in the last
fifty years. Musto and Spear invite comparison
between events in the US andthose in the UK in
those years aspolicy onbothsidesoftheAtlantic
moved closer together, aided by travel and
interaction between key players. There are some
striking similarities, despite the oft drawn
contrast between the "liberalism" of British
9Virginia Berridge, 'Drugs and social policy:
the establishment ofdrug control in Britain
1900-1930', Br. J. Addiction, 1984, 79 (1): 17-29.
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policy and the American "war on drugs". The
role of doctor advisers-Connell and others in
the UK, Boume and Jaffe in the US, is one
parallel. The Federal location of drug policy in
the States contrasts, however, with the
departmental interests and empires which have
characterized British drug policy. The role of
the inspectorate in the UK also needs to be set
within the context of inspectorial regimes in
general. The books also raise questions of
sources, methodology and interpretation. We
can reinterpret the US policy history using
Musto's document CD; Edwards' interviews
await analysis; and Bing Spear's book provides
source material for further study. Historical
analysis does not deal in "true stories" or in
"heroes and villains"; but these texts provide
rich material for the considered national and
cross national analysis which recent drug policy
still needs.
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